Related Experiment Video
Updated: Sep 13, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Risk Factors for Catatonia Relapse in Psychotic and Affective Disorders
Harsh Pathak1, Sneha Susan Varghese1, Satish Suhas1
1National Institute of Mental Health & Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Catatonia frequently recurs, with nearly half of patients relapsing within two years. Antipsychotic maintenance therapy may significantly reduce the risk of catatonia relapse.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Medicine
Background:
- Catatonia is a recurrent neuropsychiatric syndrome with poorly understood long-term course and relapse risk factors.
- Understanding relapse patterns is crucial for developing effective long-term management strategies.
Purpose of the Study:
- To investigate the rate of catatonia relapse.
- To identify demographic, clinical, and treatment-related factors associated with relapse in patients with psychotic and affective spectrum disorders.
Main Methods:
- Retrospective cohort study at a tertiary neuropsychiatric center.
- Included 303 patients with catatonia from emergency and acute care services (2014-2017).
- Utilized survival analysis (Kaplan-Meier, Cox regression) for up to 78 months follow-up.
Main Results:
- Relapse occurred in 48.8% of patients, with highest risk within 2 years of the initial episode.
- Antipsychotic prescriptions at discharge were linked to longer time to relapse and a 41.1% reduction in relapse risk.
- No significant association found between underlying psychiatric diagnosis (psychotic vs. affective) and relapse rates.
Conclusions:
- Catatonia is a recurrent condition, with a high relapse rate within the first two years.
- Antipsychotic maintenance therapy appears vital for preventing catatonia relapse.
- Further research is needed on catatonia's pathophysiology and long-term management.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Mania and Antimanic Drugs: Overview
Bipolar Disorder

